FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386003131> ?p ?o ?g. }

• W4386003131 endingPage "e003160" @default.
• W4386003131 startingPage "e003160" @default.
• W4386003131 abstract "Objectives This multicentre retrospective study in Japan aimed to assess the retention of biological disease-modifying antirheumatic drugs and Janus kinase inhibitors (JAKi), and to clarify the factors affecting their retention in a real-world cohort of patients with rheumatoid arthritis. Methods The study included 6666 treatment courses (bDMARD-naïve or JAKi-naïve cases, 55.4%; tumour necrosis factor inhibitors (TNFi) = 3577; anti-interleukin-6 receptor antibodies (aIL-6R) = 1497; cytotoxic T lymphocyte-associated antigen-4-Ig (CTLA4-Ig) = 1139; JAKi=453 cases). The reasons for discontinuation were divided into four categories (ineffectiveness, toxic adverse events, non-toxic reasons and remission); multivariate Cox proportional hazards modelling by potential confounders was used to analyse the HRs of treatment discontinuation. Results TNFi (HR=1.93, 95% CI: 1.69 to 2.19), CTLA4-Ig (HR=1.42, 95% CI: 1.20 to 1.67) and JAKi (HR=1.29, 95% CI: 1.03 to 1.63) showed a higher discontinuation rate due to ineffectiveness than aIL-6R. TNFi (HR=1.28, 95% CI: 1.05 to 1.56) and aIL-6R (HR=1.27, 95% CI: 1.03 to 1.57) showed a higher discontinuation rate due to toxic adverse events than CTLA4-Ig. Concomitant use of oral glucocorticoids (GCs) at baseline was associated with higher discontinuation rate due to ineffectiveness in TNFi (HR=1.24, 95% CI: 1.09 to 1.41), as well as toxic adverse events in JAKi (HR=2.30, 95% CI: 1.23 to 4.28) and TNFi (HR=1.29, 95%CI: 1.07 to 1.55). Conclusions TNFi (HR=1.52, 95% CI: 1.37 to 1.68) and CTLA4-Ig (HR=1.14, 95% CI: 1.00 to 1.30) showed a higher overall drug discontinuation rate, excluding non-toxicity and remission, than aIL-6R." @default.
• W4386003131 created "2023-08-20" @default.
• W4386003131 creator A5014950876 @default.
• W4386003131 creator A5018092891 @default.
• W4386003131 creator A5023433400 @default.
• W4386003131 creator A5025033858 @default.
• W4386003131 creator A5025057379 @default.
• W4386003131 creator A5026633755 @default.
• W4386003131 creator A5028081368 @default.
• W4386003131 creator A5031860797 @default.
• W4386003131 creator A5033870789 @default.
• W4386003131 creator A5039685784 @default.
• W4386003131 creator A5042692709 @default.
• W4386003131 creator A5043551691 @default.
• W4386003131 creator A5048353862 @default.
• W4386003131 creator A5055194718 @default.
• W4386003131 creator A5056011991 @default.
• W4386003131 creator A5058646134 @default.
• W4386003131 creator A5065486704 @default.
• W4386003131 creator A5070689170 @default.
• W4386003131 creator A5076008841 @default.
• W4386003131 creator A5078572977 @default.
• W4386003131 creator A5084452116 @default.
• W4386003131 creator A5086225100 @default.
• W4386003131 creator A5088759928 @default.
• W4386003131 date "2023-08-01" @default.
• W4386003131 modified "2023-10-13" @default.
• W4386003131 title "Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study" @default.
• W4386003131 cites W1858889942 @default.
• W4386003131 cites W1921689204 @default.
• W4386003131 cites W1934079113 @default.
• W4386003131 cites W1966439074 @default.
• W4386003131 cites W1989588757 @default.
• W4386003131 cites W2032121249 @default.
• W4386003131 cites W2104669609 @default.
• W4386003131 cites W2105500082 @default.
• W4386003131 cites W2106207910 @default.
• W4386003131 cites W2118561596 @default.
• W4386003131 cites W2118986661 @default.
• W4386003131 cites W2120393706 @default.
• W4386003131 cites W2121960517 @default.
• W4386003131 cites W2124227426 @default.
• W4386003131 cites W2137825059 @default.
• W4386003131 cites W2139201413 @default.
• W4386003131 cites W2149223963 @default.
• W4386003131 cites W2152348310 @default.
• W4386003131 cites W2153216198 @default.
• W4386003131 cites W2158985195 @default.
• W4386003131 cites W2284636686 @default.
• W4386003131 cites W2338749006 @default.
• W4386003131 cites W2502444878 @default.
• W4386003131 cites W2529142096 @default.
• W4386003131 cites W2543549509 @default.
• W4386003131 cites W2563857970 @default.
• W4386003131 cites W2591717879 @default.
• W4386003131 cites W2621822310 @default.
• W4386003131 cites W2791681362 @default.
• W4386003131 cites W2887186586 @default.
• W4386003131 cites W2937337452 @default.
• W4386003131 cites W2943870148 @default.
• W4386003131 cites W2944611922 @default.
• W4386003131 cites W3021665373 @default.
• W4386003131 cites W3034380047 @default.
• W4386003131 cites W3045606018 @default.
• W4386003131 cites W3082892775 @default.
• W4386003131 cites W3113314553 @default.
• W4386003131 cites W3132790041 @default.
• W4386003131 cites W3136549884 @default.
• W4386003131 cites W3153043519 @default.
• W4386003131 cites W3158439396 @default.
• W4386003131 cites W3160925247 @default.
• W4386003131 cites W3165317954 @default.
• W4386003131 cites W3201592071 @default.
• W4386003131 cites W4220675257 @default.
• W4386003131 cites W4221063728 @default.
• W4386003131 cites W4231972505 @default.
• W4386003131 cites W4281386396 @default.
• W4386003131 cites W4282913371 @default.
• W4386003131 cites W4285719527 @default.
• W4386003131 cites W4291003301 @default.
• W4386003131 cites W4308769923 @default.
• W4386003131 cites W4311621329 @default.
• W4386003131 doi "https://doi.org/10.1136/rmdopen-2023-003160" @default.
• W4386003131 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37597846" @default.
• W4386003131 hasPublicationYear "2023" @default.
• W4386003131 type Work @default.
• W4386003131 citedByCount "0" @default.
• W4386003131 crossrefType "journal-article" @default.
• W4386003131 hasAuthorship W4386003131A5014950876 @default.
• W4386003131 hasAuthorship W4386003131A5018092891 @default.
• W4386003131 hasAuthorship W4386003131A5023433400 @default.
• W4386003131 hasAuthorship W4386003131A5025033858 @default.
• W4386003131 hasAuthorship W4386003131A5025057379 @default.
• W4386003131 hasAuthorship W4386003131A5026633755 @default.
• W4386003131 hasAuthorship W4386003131A5028081368 @default.
• W4386003131 hasAuthorship W4386003131A5031860797 @default.
• W4386003131 hasAuthorship W4386003131A5033870789 @default.
• W4386003131 hasAuthorship W4386003131A5039685784 @default.

• next